drugset
Drugs / exosomes derived from human umbilical cord mesenchymal stem cells
last change Apr 2026 re-read 3 minutes ago

exosomes derived from human umbilical cord mesenchymal stem cells

Other / unclassified

Developed for
sensorineural hearing loss disorder
Investigated by
Al-Azhar University · Kafrelsheikh University · National Research Centre, Egypt

Trials 1

today NCT07568184 · not/applicable
2027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT07568184 Apr 2026 → Apr 2027 expected sensorineural hearing loss disorder Kafrelsheikh University Recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as exosomes derived from human umbilical cord mesenchymal stem cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT07568184 ↗
Modality Other / unclassified “Exosomes (30-150 nm) are natural vesicles secreted by most cell types” NCT07568184 ↗
Route Other “Intratympanic Drug Delivery” NCT07568184 ↗